IFF Completed Divestiture of Microbial Control Business
IFF (NYSE:IFF) today announced that it has successfully completed the previously announced divestiture of its Microbial Control business unit to LANXESS.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet. Learn more at iff.com , Twitter , Facebook , Instagram , and LinkedIn .
© 2022 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DE-DERMALIQ18.8.2022 18:29:11 CEST | Press release
Dermaliq Therapeutics announces first patient dosed in Phase 1b/2 trial evaluating DLQ02 for treatment of plaque psoriasis
CA-AERO-TECHNOLOGIES18.8.2022 18:02:10 CEST | Press release
Aero Secures $65M in Series B Financing to Accelerate the Future of Premium Air Travel
MA-VERISTAT18.8.2022 15:51:39 CEST | Press release
Veristat is Recognized on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies
GRAFORCE18.8.2022 14:02:05 CEST | Press release
Methane Electrolysis Can Decarbonize LNG/LPG Imports and Achieve EU’s Climate Targets
TX-SOFTSERVE18.8.2022 13:07:20 CEST | Press release
SoftServe Appoints Rishi Chohan as Executive Vice President of Banking, Financial Services, Insurance, and Retail for North America
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom